annb0t
Top 20
Immutep Limited
SYDNEY, AUSTRALIA, Feb. 18, 2022 (GLOBE NEWSWIRE) -- ImmutepLimited (ASX: IMM; NASDAQ: IMMP) ("Immutepâ or âthe Companyâ) is pleased to announce new data is scheduled to be presented at ESMOâs European Lung Cancer Congress (ELCC) 2022 which will take place in-person in Prague, Czech Republic and virtually from 30 March to 2 April 2022, Central European Summer Time (CEST).
The new data relates to Immutepâs phase II TACTI-002 trial evaluating its lead pro...
>>> Read more: Immutep to Present New Data from the Phase II TACTI-002 Study of Efti at ESMOâs European Lung Cancer Congress 2022
SYDNEY, AUSTRALIA, Feb. 18, 2022 (GLOBE NEWSWIRE) -- ImmutepLimited (ASX: IMM; NASDAQ: IMMP) ("Immutepâ or âthe Companyâ) is pleased to announce new data is scheduled to be presented at ESMOâs European Lung Cancer Congress (ELCC) 2022 which will take place in-person in Prague, Czech Republic and virtually from 30 March to 2 April 2022, Central European Summer Time (CEST).
The new data relates to Immutepâs phase II TACTI-002 trial evaluating its lead pro...
>>> Read more: Immutep to Present New Data from the Phase II TACTI-002 Study of Efti at ESMOâs European Lung Cancer Congress 2022
